Pharmacokinetics and Toxicity of Anticancer Drugs
American Journal Of Pharmacy And Pharmacology · 29.02.2024 · 5 (1) · 5-8
DOI: 10.71465/ajpp.3350 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 29.02.2024. Verfasst von Dr. Mark Stevens. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Understanding the pharmacokinetics and toxicity profiles of anticancer drugs is critical for optimizing cancer treatment and minimizing adverse effects. This article reviews the key pharmacokinetic parameters—absorption, distribution, metabolism, and excretion (ADME)—and their influence on the efficacy and safety of anticancer agents. It also explores common toxicities associated with chemotherapeutic and targeted therapies, mechanisms of drug resistance, and strategies to mitigate toxicity. The review aims to guide clinicians and researchers in selecting appropriate regimens and improving patient outcomes.
Zitieren
APA
Stevens, D. M. (2024). Pharmacokinetics and Toxicity of Anticancer Drugs. American Journal Of Pharmacy And Pharmacology, 5(1), 5-8. https://doi.org/10.71465/ajpp.3350
Vancouver
Stevens DM. Pharmacokinetics and Toxicity of Anticancer Drugs. American Journal Of Pharmacy And Pharmacology. 2024;5(1):5-8. doi:10.71465/ajpp.3350
BibTeX
@article{Stevens2024,
author = {Stevens, Dr. Mark},
title = {Pharmacokinetics and Toxicity of Anticancer Drugs},
journal = {American Journal Of Pharmacy And Pharmacology},
year = {2024},
volume = {5},
number = {1},
pages = {5--8},
doi = {10.71465/ajpp.3350}
}
EUVIMED